The revitalization of traditional Chinese medicine industry should be included in the national industrial planning
March 9, more than 20 representatives from the pharmaceutical industry participated in the National People's Congress by the China Pharmaceutical Enterprise Management Association's "voice of responsibility" seminars, the development of traditional Chinese medicine industry around some of the key issues and put forward recommendations.
, "According to support, according to the law to promote"
Heilongjiang sunflower Pharmaceutical CEO Guan Yanbin said, Chinese medicine is a unique knowledge of China, we should start from the legislature to create a conducive social environment for the development of the pharmaceutical industry. According to the "State Council to support and promote the career development of Chinese medicine a number of views" requirement, effective traditional Chinese medicine to be nurtured and promoted.
Wei Fei, chairman of Guangxi bonus Pharmaceutical Representative recommends that the development of Chinese medicine to enhance the national strategic level planning. "Chinese medicine industry is the most advantage with independent intellectual property industry, from the national development and security, strategic considerations, the Chinese medicine industry should be one of the industries as the country's revitalization."
Henan Lingrui Pharmaceutical Co., Ltd., XIONG Wei-government representatives also made the same point of view, he suggested that from the national strategic level to the revitalization of the Chinese medicine industry into the industrial plan, clearly integrate traditional Chinese medicine industry resources, regulate and guide the Chinese medicine industry chain to encourage succession based on the depth of development and innovation to guide observations and to formulate specific policy measures.
Hebei Pharmaceutical Group Chairman Li Xiaoen suggested that both countries have established strategic reserves for traditional Chinese medicine database, and implement category management. In his view, can choose to have the strength of Chinese medicine Chinese herbal medicine pharmaceutical companies or large commercial enterprises as reserve units in order to ensure the emergence of epidemic types required for the supply of medicines to avoid the supply of merchandise in, the phenomenon of price inflation, and rampant fakes.
Shineway Pharmaceutical, chairman of Li Zhenjiang said the government should provide incentives to improve business access threshold to raise industrial concentration degree, increase the leading traditional Chinese medicine business support efforts to build an aircraft carrier of Chinese medicine, traditional Chinese medicine industry to enhance competitiveness. The pharmaceutical enterprises to establish a hierarchy evaluation system, for large-scale, quality excellent, scientific research strength, the advantages of strong enterprises, to give key support.
Step-step chairman Zhao recommended the establishment of Traditional Chinese Medicine on behalf of intellectual property protection coordination mechanism, the implementation of industry, intellectual property strategy, standing on a high degree of development of the industry to develop traditional Chinese medicine the guiding ideology of intellectual property protection and strategic goals, strategic focus and strategic measures.
"Improving standards to ensure the efficacy of"
GUAN Yan-bin in an interview, said China's current proprietary Chinese standard Shangchu fuzzy state, which was very accurate, is not conducive to innovation and development of traditional Chinese medicine industry and internationalization. He suggested that the optimization of existing proprietary Chinese standards, the standard of Chinese medicine into the existing varieties, those who have proven active ingredients should have a quantitative requirement, but should be based on a quantitative basis for quality products as the standard, rather than the average level of the standard . Should be encouraged to raise standards, to improve the standards of the secondary development of new drugs target species, should provide special facilities in the registration, but also to the protection of traditional Chinese medicine, patents granted preferential treatment and so on.
Henan Wanxi Pharmaceutical Co., Ltd. on behalf of chairman of Sun Yaozhi respect, the present pharmaceutical companies excessive, vicious competition, and disorderly competition. In his view, enhance corporate standards, to improve drug quality, and weed out unqualified enterprises, cultivating large enterprises, so that traditional Chinese medicine companies create brands in the international arena.
Li Xiaoen added that, from the Chinese herbal medicine should be to establish a strict standard, and form to be bound by laws and regulations.
SIU Wai recommended the development of a set of characteristics with the traditional Chinese medicine, Chinese medicine can be internationally recognized quality standard system, the promotion of traditional Chinese medicine industry to upgrade its technology to achieve leapfrog development of traditional Chinese medicine industry.
Chinese Herbal Pieces Co., Ltd. Shandong qi HUANG, Chairman Liu Jiakun delegates expressed the need to strengthen the management of Chinese Herbal Pieces management qualification, strict implementation of GMP standards, norms Pieces of Chinese medicine production, the same time, according to a new version of "Chinese Pharmacopoeia" provides raw materials for traditional Chinese medicine to regulate the use and annotation behavior .
Some representatives suggested that traditional Chinese medicine and other traditional medicines in most parts of the world have not yet incorporated into drug administration, the existing customs codes commodity code of Chinese medicine is too small, national and industry can not receive timely information on import and export of traditional Chinese medicine a single commodity, and weakens the import and export of Chinese medicine and supervision and on trade trends in research, is not conducive to the promotion of Chinese medicine import and export policy adjustments and planning, is not conducive to strive for Chinese medicine in the international legal status, is not conducive to promoting the internationalization of Chinese medicine. Based on this, it is recommended in the customs commodity code in traditional Chinese medicine as an additional commodity codes.
The e-commerce company in China offers quality products such as blue diode laser K41S14F-0.10W , red diode laser module 660nm, and more. For more , please visit laser module suppliers today!
Processing your request, Please wait....
